Lung transplantation: a decade of experience
BF Meyers, J Lynch, EP Trulock, TJ Guthrie… - Annals of …, 1999 - journals.lww.com
… Lung transplantation offers patients with end-stage lung … lungs continue to be major
problems facing lung transplant … single-lung transplants conducted for pulmonary fibrosis. Three …
problems facing lung transplant … single-lung transplants conducted for pulmonary fibrosis. Three …
Lung transplantation for patients with severe COVID-19
… develop fibrotic lung disease for which lung transplantation … matrix organization of end-stage
lung tissue from patients with … lung transplantation for idiopathic pulmonary fibrosis (IPF). …
lung tissue from patients with … lung transplantation for idiopathic pulmonary fibrosis (IPF). …
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
AF Shorr, JL Wainright, CS Cors… - European …, 2007 - Eur Respiratory Soc
… Pulmonary hypertension is common in idiopathic pulmonary fibrosis patients awaiting
lung transplant, but the elevations in mean pulmonary arterial pressure are moderate. Lung …
lung transplant, but the elevations in mean pulmonary arterial pressure are moderate. Lung …
Primary lung cancer in lung transplant recipients
ABM Olland, PE Falcoz, N Santelmo, R Kessler… - The Annals of thoracic …, 2014 - Elsevier
… younger patients who received transplants for cystic fibrosis using lungs from donors aged
… -stage disease. In heart transplant recipients, surgical resection of early-stage lung cancer is …
… -stage disease. In heart transplant recipients, surgical resection of early-stage lung cancer is …
… drugs through antifibrotic agents to lung transplantation: a long road of research, clinical attempts, and failures in the treatment of idiopathic pulmonary fibrosis
M Selman - Chest, 2002 - journal.chestnet.org
… Importantly, the higher mortality rate was observed for patients with end-stage lung disease
due to pulmonary fibrosis. For this reason, the US organ allocation system (United Network …
due to pulmonary fibrosis. For this reason, the US organ allocation system (United Network …
Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation
W Chalermskulrat, N Sood, IP Neuringer, TM Hecker… - Thorax, 2006 - thorax.bmj.com
… from the airways of end stage CF lung transplant candidates. CF … lung transplantation.
However, the overall rates of invasive disease are low and the increased risk for post-transplant …
However, the overall rates of invasive disease are low and the increased risk for post-transplant …
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease
… cystic fibrosis and 20% with COPD and Other lung diseases. … transplant recipients, but 66%
of the patients on the lung trans… of patients awaiting lung transplantation are at particular risk …
of the patients on the lung trans… of patients awaiting lung transplantation are at particular risk …
Lung transplant outcomes for idiopathic pulmonary fibrosis: are we improving?
… the Lung Allocation Score in 2005, idiopathic pulmonary fibrosis (IPF) emerged as the most
common indication for lung transplantation (… by end-stage disease, lung transplantation (LT) …
common indication for lung transplantation (… by end-stage disease, lung transplantation (LT) …
Lung transplantation and survival in children with cystic fibrosis
… lung transplantation for cystic fibrosis during the period from 1992 through 2002. Actuarial
survival for lung transplantation for cystic fibrosis … dissimilar end-stage lung diseases, whereas …
survival for lung transplantation for cystic fibrosis … dissimilar end-stage lung diseases, whereas …
Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant
F D'Ovidio, LG Singer, D Hadjiliadis, A Pierre… - The Annals of thoracic …, 2005 - Elsevier
… was examined in 78 consecutive end-stage lung disease patients assessed for lung
transplantation: emphysema, 21; cystic fibrosis, 5; idiopathic pulmonary fibrosis, 26; scleroderma, 10…
transplantation: emphysema, 21; cystic fibrosis, 5; idiopathic pulmonary fibrosis, 26; scleroderma, 10…